Multimedia

Ask the Expert: Are Blood Thinners Safe for CLL Patients?

Highlights From the 2017 iwCLL Meeting
William Werda, MD, PhD, Jeff Folloder

“Living Well with CLL” Town Meeting Morning Session
Nicole Lamanna, MD / Philip Thompson, MB, BS / Andrew Schorr

Big Pharma Joins the Patient Engagement Conversation
Andrew Schorr

What Are Monoclonal Antibodies and How Do They Treat CLL?
Zeev Estrov, MD / Michael Keating, MB, BS

CT Scans: How Much Is Too Much?
Lisa Hicks, MD / Carol Preston

Taking Charge of Your Health: Advice From a Hematologist
Robert A. Hromas, MD, FACP / Carol Preston

CLL Defined
Michael Keating, MB, BS / Nicole Lamanna, MD

Expanding Treatment Options for CLL: Session One Replay
Michael Keating, MB, BS / Kathryn Kolibaba, MD / Jeff Sharman, MD / Stephen E. Spurgeon, MD / Andrew Schorr

Expanding Treatment Options for CLL: Session Two Replay
Michael Keating, MB, BS / Kathryn Kolibaba, MD / Jeff Sharman, MD / Nora Larson, MSW, CSWA, LICSWA / Andrew Schorr

Advice for Coping With CLL Treatment Side Effects
Michael Keating, MB, BS / Nicole Lamanna, MD / Wenli Liu, MD / Brad Adams / Allen Melancon / Andrew Schorr

Treatment An Update on CAR T-Cell Therapy
Philip Thompson, MB, BS / Andrew Schorr

I’m Exhausted: Is It My CLL?
Philip Thompson, MB, BS / Andrew Schorr

Where Are We Headed With Frontline CLL Treatment Approaches?
John Gribben, MD, DScn, FRCPath, FRCP FMed / Constantine S. Tam, MBBS, MD / Andrew Schorr

The Evolving CLL Treatment Landscape
Richard Furman, MD / Andrew Schorr

What Could a New Drug Approval Mean for CLL Patients?
William Wierda, MD, PhD

Breaking News: Expert Perspective on Venclexta (venetoclax) Approval
Thomas Kipps, MD, PhD

Expert Advice on CLL and Supplements
Zeev Estrov, MD / Michael Keating, MB, BS / Nicole Lamanna, MD

Breaking News: Six Idelalisib (Zydelig) Combination Trials Halted
Jeff Sharman, MD

Combining CLL Treatments
John Gribben, MD, DScn, FRCPath, FRCP FMed / Constantine S. Tam, MBBS, MD / Prof. William Wierda

An Expert Panel Discusses Immunotherapy and CLL
John Gribben, MD, DScn, FRCPath, FRCP FMed / Andrew Schorr / Constantine S. Tam, MBBS, MD / William Wierda, MD, PhD

What Are Monoclonal Antibodies and How Do They Treat CLL?
Zeev Estrov, MD / Michael Keating, MB, BS

Emerging Immunotherapy Options for CLL
Zeev Estrov, MD / Michael Keating, MB, BS / Nicole Lamanna, MD

Managing and Monitoring CLL Treatment Side Effects
Nicole Lamanna, MD / Jamie Lynn Gibbons, PA

Understanding the Relationship Between Genetic Testing and Targeted Therapy
Michael Keating, MB, BS / Nicole Lamanna, MD

Ask the Expert: Should Genetic Tests Be Repeated?
Michael Keating, MB, BS

Dr. Susan O’Brien: My Reflections on ASH 2015
Susan M. O’Brien, MD, Associate Director for Clinical Sciences, Chao Family Comprehensive Cancer Center

A Review of CLL Chemotherapy Approaches
Michael Keating, MB, BS / Nicole Lamanna, MD

Treating CLL With Immunotherapy: How Is Research Evolving?
Prof. William Wierda / Andrew Schorr

An Expert’s Review of CLL ASH 2015 News
Prof. William Wierda

Combining New and Emerging CLL Treatments
Michael Keating, MB, BS

ASH 2015: Promising Combination Treatment Approaches
Dr. Andrew Zelenetz / Carol Preston

An Expert’s Update on ROR1
Thomas Kipps, MD, PhD / Andrew Schorr

The Benefits of Exercise During CLL Treatment
Nicole Lamanna, MD / Wenli Liu. MD / Michael Keating, MB, BS / Andrew Schorr

Living Well with CLL You Don’t Have to Suffer: Finding Relief for Cancer Pain
David Hui, MD, MSc / Andrew Schorr

What Should CLL Patients Know About Vaccines?
Nicole Lamanna, MD / Andrew Schorr

CLL and Travel: Is It Safe?
Michael Keating, MB, BS

Big Pharma Joins the Patient Engagement Conversation
Andrew Schorr

Breaking the Cancer Silence
Cherry Sloan-Medrano, RN, BSN, CCM, BC, OCN

What Does Living Well With CLL Mean?
Jamie Lynn Gibbons, PA / Jeff Folloder / Andrew Schorr

Expert Advice on CLL and Supplements
Zeev Estrov, MD / Michael Keating, MB, BS / Nicole Lamanna, MD

Andrew Schorr’s Video Blog on Community Oncology
Andrew Schorr

Bob Stamp: Putting CLL in the Rearview Mirror
Bob Stamp

Managing and Monitoring CLL Treatment Side Effects
Nicole Lamanna, MD / Jamie Lynn Gibbons, PA